COVID-19 vaccine: Spain okays Pfizer jab for under-60s who got AstraZeneca's first dose
The proposal will affect about 1.5 million Spaniards who received the AstraZeneca shot before the government banned it for those aged under 60 due to blood clot concerns
AstraZeneca Pharma India Ltd - 506820 - Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company To Be Held On Tuesday, May 25, 2021
ASTRAZENECA PHARMA INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2021 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors of AstraZeneca Pharma India Limited will be held on Tuesday, May 25, 2021 inter alia, to consider and approve the Audited Financial Results of the Company for the quarter and year ended March 31, 2021. We would also like to inform you that the 'Trading Window' remains closed for all Designated Persons, from March 16, 2021 to May 27, 2021 (both days inclusive) in terms of AstraZeneca Pharma India Limited - Code of Conduct for Prevention of Insider Trading framed under Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015.
Norway excludes AstraZeneca from vaccination campaign, says PM Erna Solberg
Norway has removed the vaccine against Covid-19 made by AstraZeneca from its inoculation campaign, Prime Minister Erna Solberg said.
Will raise monthly production of vaccines to 100 mn doses by August: Serum
Amid multiple states reporting a shortage of COVID-19 vaccine, Serum Institute and Bharat Biotech have submitted to the Centre their production plan for the next four months, informing they can ramp it up to 10 crore and 7.8 crore doses respectively by August, official sources said on Wednesday The sources said the Union Health Ministry and the office of Drugs Controller General of India had sought from both the firms their production plan for June, July, August and September. The Hyderabad-based Bharat Biotech's indigenously developed Covaxin and Oxford-AstraZeneca's Covishield, being manufactured by the Pune-based Serum Institute of India, are currently being used in India's inoculation drive against coronavirus. Dr V Krishna Mohan, the Whole-time Director of Bharat Biotech, is learnt to have conveyed to the government that the production of Covaxin would be raised to 3.32 crore in July, and to 7.82 crore in August which will be maintained in September too. Similarly, Prakash Kum
AstraZeneca pledges $250,000 as humanitarian aid to India amid COVID-19 crisis
The aid to India is part of the $1 million which the British-Swedish multinational has earmarked for relief initiatives across communities which have been hit hard by the coronavirus pandemic
AstraZeneca weighs seeking full US approval for Covid shot, skipping emergency-use application
British drugmaker faces challenges gathering data; may wait to apply for full approval by the FDA, which takes longer Under-40s in UK to get an alternative to Oxford-AstraZeneca vaccine
The Joint Committee on Vaccination and Immunisation (JCVI) update extends its previous advice for all under-30s to be given an alternative jab
Gap between AstraZeneca doses can be as little as 4 weeks: Germany
Germany defends AstraZeneca pivot as key to speeding Covid vaccinations; experts warn on reduced efficacy with shorter gap
Nepal overwhelmed by surge in COVID-19 infections
Nepal faces rising infections as India's outbreak spreads across South Asia. Nepal urgently needs at least 1.6 million AstraZeneca's (AZN.L) COVID-19 vaccine doses to administer second shots as the Himalayan country is recording a surge in new coronavirus cases.
US President Biden hopes to send AstraZeneca vaccine to countries by July 4
President Joe Biden provided an update on White House on goals for providing AstraZeneca Covid-19 vaccines to countries by July 4